http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0146810-A3
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate | 1984-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1987-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0146810-A3 |
| titleOfInvention | Process for the preparation of sphingosin derivatives |
| abstract | New compounds of the formula are describedn(I) -D and (I) -L according to the formula sheet, for example D- ornL-erythro-1- (β-D-glucopyranosyloxy) -3-hydroxy-2-npalmitoylamino-4-trans-octadecen, which is a woundnWe promote the development of cells and cells and tissuesnexercise and treat any woundsnGenesis can be used therapeutically. You whonthose of ceramides of the formula (II) -D and / or (II) -L with goodnYield and in stereochemically uniform formnposes. The procedure includes the protection of 1-nHydroxyl group, the esterification of the 3-hydroxyl group, thenCleavage of the 1-hydroxyl protecting group, the reaction withnthe trifluoro or trichloroacetimidate of a 2,3,4,6-tetraacynD-glucose and the cleavage of the O-acyl groups.nWhen using a D, L-ceramide (II) the verestention of the 3-hydroxyl group by an optically active acidnperformed, followed by separation into the diastereomasnren, or after the implementation with the D-nGlucose derivative featured a separation into the diastereomersntaken. |
| priorityDate | 1983-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.